Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

PHARMACOTHERAPY AND EVIDENCE BASED MEDICINE: Edited by Enrico Compalati and Derek Chu

β-Blockers and angiotensin-converting enzyme inhibitors with sublingual immunotherapy: are risks related to individual product safety profile?

Smith, Derek M.a; Coop, Christopher A.a; Freeman, Theodore M.b

Author Information
Current Opinion in Allergy and Clinical Immunology: August 2020 - Volume 20 - Issue 4 - p 401-406
doi: 10.1097/ACI.0000000000000657
  • Buy

Abstract

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.